Cognizant and Fortrea partner for technology transformation in life sciences

Cognizant (Nasdaq: CTSH) and Fortrea (Nasdaq: FTRE), a prominent provider of clinical development and patient access solutions, announced a strategic partnership where Cognizant will act as Fortrea’s technology transformation provider.

The four-year agreement focuses on transforming Fortrea’s global technology environment, incorporating next-generation hybrid cloud and digital platforms.

This partnership aims to advance Fortrea’s mission in delivering enhanced solutions to the pharmaceutical, biotechnology, and medical device sectors.

Cognizant’s approach is expected to bring agility and speed necessary for deploying state-of-the-art technologies and services. These advancements are designed to enable Fortrea to transform into a “born digital” organization, ensuring efficient digital experiences across various touchpoints. The focus is on creating a seamless digital experience with agility and efficiency, supporting Fortrea’s transition to a modern digital infrastructure.

Fortrea Chooses Cognizant for Advancing Digital Innovation in Clinical Solutions

This agreement builds upon the existing relationship between HASI and AES. It follows HASI’s investment in a 1.3-GW portfolio of solar and wind projects with AES in January 2023. The partnership reflects their shared commitment to accelerating energy transition through sustainable solutions.

Alejandro Martinez Galindo, CIO of Fortrea, highlighted the importance of investing in clinical applications and platforms to speed up the delivery of life-changing treatments. Cognizant’s expertise will play a crucial role in realizing Fortrea’s vision for a modern digital ecosystem. Prasad Sankaran, EVP at Cognizant, and Surya Gummadi, EVP & President of the Americas at Cognizant, both emphasized their commitment to assisting Fortrea in fortifying its position as a digital, global Contract Research Organization (CRO).

The partnership between Cognizant and Fortrea is set to elevate Fortrea’s data and analytical capabilities, setting new industry standards in the CRO sector. The collaboration is expected to drive modernization across Fortrea’s global operations, benefiting their customers, including leading enterprises in the industry.

The strategic partnership between Cognizant and Fortrea marks a pivotal step in the digital transformation of the life sciences industry. By leveraging Cognizant’s expertise in technology, Fortrea is poised to enhance its digital infrastructure, thereby improving patient access and clinical development. This collaboration signifies a significant advancement in the use of technology to facilitate growth and innovation in healthcare and clinical research.